97 research outputs found
Homochiral Silver-Based Coordination Polymers Exhibiting Temperature-Dependent Photoluminescence Behavior
Homochiral
coordination polymers based on zigzag or helical polymers are assembled
from a semiflexible fluorescent bipyridyl ligand and linear coordinated
Ag<sup>I</sup> ions; they exhibit unusual temperature-dependent photoluminescence
behavior, including multistep changes in energy and intensity upon
cooling
Homochiral Silver-Based Coordination Polymers Exhibiting Temperature-Dependent Photoluminescence Behavior
Homochiral
coordination polymers based on zigzag or helical polymers are assembled
from a semiflexible fluorescent bipyridyl ligand and linear coordinated
Ag<sup>I</sup> ions; they exhibit unusual temperature-dependent photoluminescence
behavior, including multistep changes in energy and intensity upon
cooling
Porous and Robust Lanthanide Metal-Organoboron Frameworks as Water Tolerant Lewis Acid Catalysts
Porous and robust 12-connected metal–organic
frameworks
(MOFs) were constructed by linking tetranuclear lanthanide (Ln) carbonate
clusters with organoboron-derived tricarboxylate bridging ligands.
The high-connectivity Ln-MOFs feature remarkable thermal and hydrolytic
stability and a large number of isolated Lewis acid BÂ(III) and LnÂ(III)
sites on the pore surfaces. The Nd-MOF assisted with sodium dodecylsulfate
was found to be highly effective, recyclable, and reusable heterogeneous
catalyst for the carbonyl allylation reaction, the Diels–Alder
reaction, and the Strecker-type reaction in water. The transformations
were cocatalyzed by NdÂ(III) and BÂ(III) Lewis acids, with activities
much higher than those of the individual organoboron and lanthanide
counterparts and their mixture. This work highlights the potential
of generating highly efficient water-tolerant solid catalysts via
heterogenization of different weak and/or mild Lewis acids in confined
spaces of robust MOFs
Porous and Robust Lanthanide Metal-Organoboron Frameworks as Water Tolerant Lewis Acid Catalysts
Porous and robust 12-connected metal–organic
frameworks
(MOFs) were constructed by linking tetranuclear lanthanide (Ln) carbonate
clusters with organoboron-derived tricarboxylate bridging ligands.
The high-connectivity Ln-MOFs feature remarkable thermal and hydrolytic
stability and a large number of isolated Lewis acid BÂ(III) and LnÂ(III)
sites on the pore surfaces. The Nd-MOF assisted with sodium dodecylsulfate
was found to be highly effective, recyclable, and reusable heterogeneous
catalyst for the carbonyl allylation reaction, the Diels–Alder
reaction, and the Strecker-type reaction in water. The transformations
were cocatalyzed by NdÂ(III) and BÂ(III) Lewis acids, with activities
much higher than those of the individual organoboron and lanthanide
counterparts and their mixture. This work highlights the potential
of generating highly efficient water-tolerant solid catalysts via
heterogenization of different weak and/or mild Lewis acids in confined
spaces of robust MOFs
A Homochiral Metal–Organic Framework as an Effective Asymmetric Catalyst for Cyanohydrin Synthesis
A homochiral
metal–organic framework (MOF) of an enantiopure
2,2′-dihydroxy-1,1′-biphenyl ligand was constructed.
After exchanging one proton of the dihydroxyl group for LiÂ(I) ions,
the framework is shown to be a highly efficient and recyclable heterogeneous
catalyst for asymmetric cyanation of aldehydes with up to >99%
ee.
Compared with the homogeneous counterpart, the MOF catalyst exhibits
significantly enhanced catalytic activity and enantioselectivity,
especially at a low catalyst/substrate ratio, due to that the rigid
framework could stabilize the catalytically active monolithium salt
of biphenol against its free transformation to catalytically inactive
and/or less active assemblies in reactions. The synthetic utility
of the cyanation was demonstrated in the synthesis of (<i>S</i>)-bufuralol (a nonselective β-adrenoceptor blocking agent)
with 98% ee
Image_1_Case report: Temozolomide induced hypermutation: an indicator associated with immunotherapy response in patient with gliomas.jpeg
BackgroundTemozolomide (TMZ) is a key component in the treatment of gliomas. Hypermutation induced by TMZ can be encountered in routine clinical practice, and its significance is progressively gaining recognition. However, the relationship between TMZ-induced hypermutation and the immunologic response remains controversial.Case presentationWe present the case of a 38-year-old male patient who underwent five surgeries for glioma. Initially diagnosed with IDH-mutant astrocytoma (WHO grade 2) during the first two surgeries, the disease progressed to grade 4 in subsequent interventions. Prior to the fourth surgery, the patient received 3 cycles of standard TMZ chemotherapy and 9 cycles of dose-dense TMZ regimens. Genomic and immunologic analyses of the tumor tissue obtained during the fourth surgery revealed a relatively favorable immune microenvironment, as indicated by an immunophenoscore of 5, suggesting potential benefits from immunotherapy. Consequently, the patient underwent low-dose irradiation combined with immunoadjuvant treatment. After completing 4 cycles of immunotherapy, the tumor significantly shrank, resulting in a partial response. However, after a 6-month duration of response, the patient experienced disease progression. Subsequent analysis of the tumor tissue obtained during the fifth surgery revealed the occurrence of hypermutation, with mutation signature analysis attributing TMZ treatment as the primary cause. Unfortunately, the patient succumbed shortly thereafter, with a survival period of 126 months.ConclusionPatients subjected to a prolonged regimen of TMZ treatment may exhibit heightened vulnerability to hypermutation. This hypermutation induced by TMZ holds the potential to function as an indicator associated with unfavorable response to immunotherapy in gliomas.</p
Table_1_Case report: Temozolomide induced hypermutation: an indicator associated with immunotherapy response in patient with gliomas.docx
BackgroundTemozolomide (TMZ) is a key component in the treatment of gliomas. Hypermutation induced by TMZ can be encountered in routine clinical practice, and its significance is progressively gaining recognition. However, the relationship between TMZ-induced hypermutation and the immunologic response remains controversial.Case presentationWe present the case of a 38-year-old male patient who underwent five surgeries for glioma. Initially diagnosed with IDH-mutant astrocytoma (WHO grade 2) during the first two surgeries, the disease progressed to grade 4 in subsequent interventions. Prior to the fourth surgery, the patient received 3 cycles of standard TMZ chemotherapy and 9 cycles of dose-dense TMZ regimens. Genomic and immunologic analyses of the tumor tissue obtained during the fourth surgery revealed a relatively favorable immune microenvironment, as indicated by an immunophenoscore of 5, suggesting potential benefits from immunotherapy. Consequently, the patient underwent low-dose irradiation combined with immunoadjuvant treatment. After completing 4 cycles of immunotherapy, the tumor significantly shrank, resulting in a partial response. However, after a 6-month duration of response, the patient experienced disease progression. Subsequent analysis of the tumor tissue obtained during the fifth surgery revealed the occurrence of hypermutation, with mutation signature analysis attributing TMZ treatment as the primary cause. Unfortunately, the patient succumbed shortly thereafter, with a survival period of 126 months.ConclusionPatients subjected to a prolonged regimen of TMZ treatment may exhibit heightened vulnerability to hypermutation. This hypermutation induced by TMZ holds the potential to function as an indicator associated with unfavorable response to immunotherapy in gliomas.</p
A Novel and Versatile Strategy to Prepare Metal–Organic Molecular Precursor Solutions and Its Application in Cu(In,Ga)(S,Se)<sub>2</sub> Solar Cells
A novel and versatile metal–organic molecular
precursor-based solution approach and the fabrication of high efficiency
CuÂ(In,Ga)Â(S,Se)<sub>2</sub> solar cells are presented. Many types
of metal oxides, hydroxides, and acetylacetonates (acac), such as
Cu<sub>2</sub>O, ZnO, SnO, Sb<sub>2</sub>O<sub>3</sub>, MnO, PbO,
InÂ(OH)<sub>3</sub>, CdÂ(OH)<sub>2</sub>, GaÂ(acac)<sub>3</sub>, and
so forth, can be easily dissolved in butyldithiocarbamic acid, forming
thermally degradable metal–organic molecular precursor solutions.
By developing a simple and green ethanol solution-processed route
and tuning the chemical composition of the CuÂ(In,Ga)Â(S,Se)<sub>2</sub> thin film, as-fabricated solar cells exhibit an average power conversion
efficiency up to 8.8%
Chiral Metal–Organic Framework Decorated with TEMPO Radicals for Sequential Oxidation/Asymmetric Cyanation Catalysis
A chiral
porous metal–organic framework (MOF) decorated with radicals
has been successfully constructed by cocrystallizing achiral (2,2,6,6-tetramethylpiperidin-1-yl)Âoxyl
(TEMPO)-substituted tricarboxylate and enantiopure VOÂ(salen)-derived
dipyridine ligands. The chiral MOF can function as an efficient heterogeneous catalyst for the
sequential alcohol oxidation/asymmetric cyanation of aldehyde reactions
with enhanced activity and enantioselectivity compared to the homogeneous
counterpart
Identification of a Plasma Four-microRNA Panel as Potential Noninvasive Biomarker for Osteosarcoma
<div><p>Background</p><p>Circulating microRNAs (miRNAs) are emerging as promising biomarkers for human cancer. Osteosarcoma is the most common human primary malignant bone tumor in children and young adults. The objective of this study was to investigate whether circulating miRNAs in plasma could be a useful biomarker for detecting osteosarcoma and monitoring tumor removal dynamics.</p><p>Methods</p><p>Plasma samples were obtained from 90 patients before surgery, 50 patients after one month of surgery, and 90 healthy individuals. The study was divided into three steps: First, initial screening of the profiles of circulating miRNAs in pooled plasma samples from healthy controls and pre-operative osteosarcoma patients using a TaqMan low density array (TLDA). Second, evaluation of miRNA concentration in individual plasma samples from 90 pre-operative osteosarcoma patients and 90 healthy controls by a quantitative real time PCR (qRT-PCR) assay. Third, evaluation of miRNA concentration in paired plasma samples from 50 pre- and post-operative osteosarcoma patients by qRT-PCR assay.</p><p>Results</p><p>Four plasma miRNAs including miR-195-5p, miR-199a-3p, miR-320a, and miR-374a-5p were significantly increased in the osteosarcoma patients. Receiver operating characteristics curve analysis of the combined populations demonstrated that the four-miRNA signature could discriminate cases from controls with an area under the curve of 0.9608 (95% CI 0.9307-0.9912). These 4 miRNAs were markedly decreased in the plasma after operation. In addition, circulating miR-195-5p and miR-199a-3p were correlated with metastasis status, while miR-199a-3p and miR-320a were correlated with histological subtype.</p><p>Conclusions</p><p>Our data suggest that altered levels of circulating miRNAs might have great potential to serve as novel, non-invasive biomarkers for osteosarcoma.</p></div
- …